Searchable abstracts of presentations at key conferences in endocrinology

ea0025p38 | Clinical biochemistry | SFEBES2011

Hypocalcaemia presenting via an acute medical admissions unit is only rarely adequately investigated

Griffiths Rebecca , Pattman Stewart , Quinton Richard

Aim: To determine whether cases of hypocalcaemia presenting via an emergency medical admissions unit (EAU) are appropriately investigated.Background: Hypocalcaemia is a potentially life threatening abnormality, with a prevalence of 18% among hospital inpatients.1,2 Risk factors include vitamin D deficiency, renal disease, hypoparathyroidism (typically post-neck surgery) and hypomagnesaemia. A reasonable investigational dataset comprises U+Es a...

ea0025p90 | Clinical biochemistry | SFEBES2011

Multiple endocrine dysfunction in the context of psychiatric medication

Carroll Richard , Meeran Karim , Todd Jeannie

MM, a 51-year-old female was reviewed in the Endocrinology clinic for the assessment of hypercalcaemia, hyperprolactinaemia, and an adrenal mass. Bipolar depression had been diagnosed 24 years previously with continuous use of Lithium Carbonate since. An acute deterioration in mental state 3 years previously prompted Risperidone treatment which was ongoing. Hypercalcaemia (calcium=2.78 mmol/l, PTH=13.8 pmol/l, vitamin D=33 nmol/l) was recorded. Polyuria and nocturia was noted....

ea0020p277 | Clinical case reports and clinical reports | ECE2009

Polyuria as a main feature of parathyroid crisis due to parathyroid glands hyperplasia

Bogatyriow Oleg , Parhimovich Richard , Kotova Irina

Aim: To present a case of severe primary hyperparathyroidism (PHPT) manifested predominantly with polyuria.Case: A 53 years old caucasian female presented to the emergency room with polyuria (5-6 l), and increasing during last 4 weeks dehydration, weight loss (10 kg), weakness, confusion. Diabetes mellitus and insipidus had been excluded. After hypercalcemia (3.6–3.9 mmol\l), Ca++ to 2.0 mmol\l and PTH of 616 pg\ml (11–62) were revealed acute P...

ea0013p6 | Bone | SFEBES2007

Endocrine effects of depot medroxyprogesterone acetate in young women

Walsh Jennifer , Eastell Richard , Peel Nicola

The injectable contraceptive depot medroxyprogesterone acetate (DMPA, Depo-Provera®) is used by over nine million women worldwide. It induces amenorrhoea, raising concern about effects on bone density. This study aims to ascertain if the skeletal effects of DMPA are age-specific and to identity the mechanisms through which DMPA acts on the skeleton. The study was approved by the local Ethics Committee. We recruited 100 pairs of women ages 18–25 and 35&#150...

ea0013p68 | Clinical practice/governance and case reports | SFEBES2007

Recurrent cystic pituitary lesion - A case report

Sukesh Chandran K , Advani Andrew , Quinton Richard

41 year old male presented in 1992 with 2 years history of blurring of vision, headaches, dizzy spells. Had Right supratemporal visual field defect, pituitary MRI which showed cystic pituitary lesion. Had TSS in May 1992 and histology showed Rathkes pouch cyst. Post operatively developed DI and started on DDAVP.SST,TRH and GnRH tests were normal. Persisted retro orbital head aches, developed nasal and temporal field loss. MRI in Sept 1992 showed large intrasellar recurrence of...

ea0013p249 | Neuroendocrinology and behaviour (including pituitary) | SFEBES2007

Sleep disorders in craniopharyngioma patients – a preliminary report

Crowley Rachel , Costello Richard , Thompson Christopher

Objective: Our aim was to identify and treat sleep disorders in asymptomatic patients with craniopharyngioma and to identify co-existing respiratory disease.Methods: 5 patients (1 male) with a diagnosis of craniopharyngioma, were identified from the local pituitary database and admitted for polysomnography (Alice 4, Respironics), as part of a study of hypothalamic disease in craniopharyngioma. Sleep disturbance was defined as an apnoea index (AHI) of &#6...

ea0011oc48 | Endocrine genetics | ECE2006

Progressive osseous heteroplasia: a phenotype associated with mutations of the GNAS1 gene

Richard N , Abeguile G , Kottler ML

Progressive osseous heteroplasia (POH, MIM 166350) is a rare autosomal dominant disorder characterised by extensive dermal ossification during childhood, followed by widespread heterotopic ossification of skeletal muscle and deep connective tissue. Recently, genetic basis was found to be common with Albright’s hereditary osteodystrophy (AHO) (Shore et al., 2002): paternally inherited inactivating mutations of the GNAS1 gene were found. GNAS1 is the ge...

ea0074ncc7 | Highlighted Cases | SFENCC2021

A rare case of metastatic prolactinoma presenting with cervical myelopathy

Bashiti Hazem , Broughton Chloe , Nelson Richard

Case History: A 52 year old man presented in 2009 with a gradual loss of peripheral vision associated with headaches. Examination confirmed bi-temporal hemianopia. Further investigation revealed elevated prolactin levels and pituitary MRI showed evidence of large pituitary tumour. A diagnosis of macroprolactinoma was made and cabergoline was commenced. Given resistance to medical treatment, the patient required two surgical resections (2011 and 2013) and radical radiotherapy (...

ea0041ep937 | Pituitary - Clinical | ECE2016

Trial design of a phase III, multicentre, randomised, double-blind, placebo-controlled, 48-week study to evaluate the safety and efficacy of osilodrostat in patients with Cushing’s disease

Feelders Richard A , Heaney Anthony , McBride Karen , Hilliard Annie , Tian Chuan , Sauter Nicholas , Auchus Richard J

Background: Osilodrostat is an oral inhibitor of 11β-hydroxylase (CYP11B1), the enzyme that catalyses the final step in cortisol biosynthesis. In a 22-week, phase II study, osilodrostat treatment normalised mean urinary free cortisol (mUFC) in 78.9% (15/19) of patients with uncontrolled Cushing’s disease and was well tolerated. The present phase 3 study is designed to confirm the safety and efficacy of osilodrostat in patients with uncontrolled Cushing’s disease...

ea0038p43 | Clinical practice/governance and case reports | SFEBES2015

What is the prevalence of severe post-operative hypocalcaemia in patients who have undergone parathyroid surgery or a total thyroidectomy at the RVI, Newcastle? Does vitamin D play a role?

Pawlak Anna , Quinton Richard , Truran Peter , Lennard Thomas , Bliss Richard , Heed Andrew

Background: Hypocalcaemia is a common electrolyte disorder and it can occur following parathyroidectomy or thyroidectomy. It has been suggested that some post-operative hypocalcaemic crises may reflect severe vitamin D deficiency and vitamin D supplementation may have a protective effect.Objectives: To establish the prevalence of severe post-operative hypocalcaemia (as defined by the requirement for i.v. calcium gluconate) following parathyroid surgery a...